Northern Trust’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$52.4M Sell
444,746
-1,402
-0.3% -$196K 0.01% 1068
2025
Q4
$73.1M Sell
446,148
-17,978
-4% -$2.82M 0.01% 896
2025
Q3
$62M Sell
464,126
-5,696
-1% -$692K 0.01% 992
2025
Q2
$58.4M Sell
469,822
-28,625
-6% -$3.64M 0.01% 998
2025
Q1
$63.4M Buy
498,447
+4,734
+1% +$729K 0.01% 949
2024
Q4
$71.1M Buy
493,713
+102,011
+26% +$14.6M 0.01% 909
2024
Q3
$58.3M Sell
391,702
-57,577
-13% -$8.26M 0.01% 927
2024
Q2
$56.6M Buy
449,279
+55,664
+14% +$8.72M 0.01% 926
2024
Q1
$72.4M Sell
393,615
-53,823
-12% -$10.3M 0.01% 772
2023
Q4
$80.4M Sell
447,438
-24,481
-5% -$3.81M 0.01% 708
2023
Q3
$75M Buy
471,919
+11,204
+2% +$1.83M 0.01% 711
2023
Q2
$65.2M Buy
460,715
+5,025
+1% +$806K 0.01% 793
2023
Q1
$76.7M Buy
455,690
+3,401
+0.8% +$607K 0.02% 700
2022
Q4
$76.6M Buy
452,289
+52,711
+13% +$9.56M 0.02% 685
2022
Q3
$74.8M Sell
399,578
-1,368
-0.3% -$288K 0.02% 657
2022
Q2
$65.1M Sell
400,946
-14,384
-3% -$2.27M 0.01% 734
2022
Q1
$78.1M Sell
415,330
-8,531
-2% -$1.62M 0.01% 751
2021
Q4
$112M Sell
423,861
-6,174
-1% -$1.66M 0.02% 628
2021
Q3
$124M Sell
430,035
-9,105
-2% -$2.34M 0.02% 583
2021
Q2
$87.7M Sell
439,140
-8,765
-2% -$1.7M 0.02% 739
2021
Q1
$87.1M Buy
447,905
+36,532
+9% +$7.49M 0.02% 737
2020
Q4
$78.8M Buy
411,373
+1,164
+0.3% +$212K 0.02% 760
2020
Q3
$60.5M Sell
410,209
-6,310
-2% -$902K 0.01% 790
2020
Q2
$51.5M Sell
416,519
-415,844
-50% -$48.9M 0.01% 874
2020
Q1
$80.4M Buy
832,363
+4,247
+0.5% +$410K 0.02% 568
2019
Q4
$76.6M Sell
828,116
-3,536
-0.4% -$297K 0.02% 714
2019
Q3
$63.8M Buy
831,652
+267,171
+47% +$23.4M 0.02% 801
2019
Q2
$48.5M Buy
564,481
+22,008
+4% +$1.5M 0.01% 1030
2019
Q1
$32M Sell
542,473
-55
-0% -$3.16K 0.01% 1313
2018
Q4
$28.6M Sell
542,528
-11,467
-2% -$673K 0.01% 1282
2018
Q3
$30.7M Buy
553,995
+10,178
+2% +$525K 0.01% 1432
2018
Q2
$25.6M Buy
543,817
+27,062
+5% +$1.11M 0.01% 1576
2018
Q1
$18.7M Buy
516,755
+4,174
+0.8% +$147K ﹤0.01% 1733
2017
Q4
$18.6M Sell
512,581
-4,119
-0.8% -$149K ﹤0.01% 1763
2017
Q3
$19.8M Buy
516,700
+22,815
+5% +$956K 0.01% 1711
2017
Q2
$20.5M Buy
493,885
+12,799
+3% +$486K 0.01% 1654
2017
Q1
$16.9M Buy
481,086
+1,842
+0.4% +$58.3K ﹤0.01% 1757
2016
Q4
$14.8M Sell
479,244
-58,351
-11% -$1.8M ﹤0.01% 1828
2016
Q3
$16.2M Buy
537,595
+50,333
+10% +$1.52M 0.01% 1737
2016
Q2
$13.3M Buy
487,262
+15,690
+3% +$401K ﹤0.01% 1823
2016
Q1
$12.7M Buy
471,572
+13,672
+3% +$335K ﹤0.01% 1805
2015
Q4
$13M Buy
457,900
+2,040
+0.4% +$58.8K ﹤0.01% 1807
2015
Q3
$12.7M Buy
455,860
+41,946
+10% +$1.52M ﹤0.01% 1821
2015
Q2
$17.1M Sell
413,914
-19,494
-4% -$714K 0.01% 1705
2015
Q1
$13.2M Buy
433,408
+42,562
+11% +$1.1M ﹤0.01% 1894
2014
Q4
$7.74M Sell
390,846
-3,313
-0.8% -$74.1K ﹤0.01% 2199
2014
Q3
$7.85M Sell
394,159
-654
-0.2% -$13.8K ﹤0.01% 2208
2014
Q2
$9M Sell
394,813
-40,141
-9% -$715K ﹤0.01% 2114
2014
Q1
$5.59M Sell
434,954
-31,331
-7% -$449K ﹤0.01% 2482
2013
Q4
$6.36M Buy
466,285
+8,108
+2% +$96.8K ﹤0.01% 2394
2013
Q3
$5.08M Sell
458,177
-330
-0.1% -$3.28K ﹤0.01% 2494
2013
Q2
$3.78M Buy
+458,507
New +$3.85M ﹤0.01% 2593

Other funds holding RGEN

Northern Trust's RGEN Position: Q1 2026 in Review

Northern Trust reduced its Repligen (RGEN) stake by 0.31% in Q1 2026, selling an estimated $196K and leaving 444,746 shares worth $52.4M. The position accounts for 0.01% of the portfolio, ranked #1068.

Northern Trust first reported a position in RGEN in Q2 2013 and has held it in 52 quarters since. The position peaked at $124M in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Northern Trust held 444,746 shares of Repligen worth $52.4M as of Q1 2026.
  • Northern Trust sold 1,402 Repligen shares in Q1 2026, an estimated $196K.
  • Repligen made up 0.01% of Northern Trust's portfolio in Q1 2026, its #1068 holding.
  • Northern Trust first reported a position in Repligen in Q2 2013 and has held it in 52 quarters since.
  • Northern Trust's Repligen position peaked at $124M in Q3 2021.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.